These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14019765)

  • 1. [Clinical study on the effect of ethyl flavone-7-oxyacetate in 34 cases of angina pectoris].
    CESARMAN VITIS T; GIORDANO M
    Prensa Med Mex; 1962; 27():343-6. PubMed ID: 14019765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of flavone-7-hydroxyethylactate in angina pectoris].
    MASONI A; FINZI CM
    Minerva Med; 1957 Nov; 48(93):3908-14. PubMed ID: 13503875
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new coronary vasodilator: flavone-7-hydroxy ethyl acetate].
    MARRAMA P; VECCHI GP
    Folia Cardiol; 1956 Aug; 15(4):419-34. PubMed ID: 13375735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic angina with ethyl-flavone-7-oxyacetate].
    Soulié P; Gaudeau S
    Coeur Med Interne; 1971; 10(2):301-4. PubMed ID: 5568275
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological properties of some new coronary dilators, particularly of flavone-7-ethyl-oxyacetate].
    SETNIKAR I; ZANOLINI T
    Farmaco Sci; 1956; 11(10):855-82. PubMed ID: 13414855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ethyl-7-hydroxyaceto-flavone (recordil) in the therapy of angina pectoris and its effects on hemodynamics and renal function].
    STRAUSAK A; COTTIER P; SCHMID A
    Cardiologia (Basel); 1959; 34(2):138-46. PubMed ID: 13629509
    [No Abstract]   [Full Text] [Related]  

  • 7. [PHARMACOLOGICAL AND TOXICOLOGICAL STUDY OF A CORONARY VASODILATOR: ETHYL FLAVONE-7-OXYACETATE].
    MORIN H; ROUX M; JACHIET MT
    Therapie; 1964; 19():1555-68. PubMed ID: 14242727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. Other angina pectoris agents].
    Lumholtz IB
    Sygeplejersken; 1980 May; 80(20):23. PubMed ID: 6902553
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous vasodilator in angina pectoris.
    VIGRAN IM
    West Med Med J West; 1962 Nov; 3():423-30. PubMed ID: 13997186
    [No Abstract]   [Full Text] [Related]  

  • 10. [RA-8 in the treatment of angina pectoris].
    LOZADA BB; FRANCO RJ
    Sem Med; 1960 Oct; 117():1227-31. PubMed ID: 13763896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chromocor, a remedy of value in angina pectoris].
    HOOGERWERF S
    Geneeskd Gids; 1955 Sep; 33(18):368-71. PubMed ID: 13262539
    [No Abstract]   [Full Text] [Related]  

  • 12. A TRIAL OF BENZIODARONE (CARDIVIX) IN ANGINA PECTORIS.
    BLAKE S; KEELAN D
    J Ir Med Assoc; 1964 Feb; 54():42-3. PubMed ID: 14117208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological studies on flavone-7-ethyl oxyacetate].
    KANDA Z; SEKIYA A; KONO C
    Nihon Yakurigaku Zasshi; 1962 Nov; 58():459-66. PubMed ID: 13962164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Place and value of the maleate of ethyl cinepazate (vascoril) among the anti-angina agents].
    Garbarg S
    Boll Soc Ital Cardiol; 1976; 21(9):1735-7. PubMed ID: 1031333
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE THERAPEUTIC VALUE OF BENZIODARONE IN ANGINA PECTORIS].
    WAREMBOURG H; STALNIKIEWICZ G
    Lille Med; 1964 Mar; 9():297-305. PubMed ID: 14141059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analytic research on ethyl flavone-7-hydroxyacetate].
    BELLOMONTE G; CARDINI C
    Rend Ist Sup Sanit; 1959; 22():613-8. PubMed ID: 13798602
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of cortisone derivatives in the therapy of angina pectoris].
    SANDRI S
    Arcisp S Anna Ferrara; 1962; 15():815-33. PubMed ID: 13976271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angina pectoris: improving symptoms and prognosis. With ivabradine less angina pectoris and reduced need for nitrates].
    MMW Fortschr Med; 2011 Jun; 153(24-25):56-7. PubMed ID: 21717715
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation on treatment of 45 angina pectoris patients of coronary heart disease with taponin].
    Liu KY; Zhang Y; Feng ZX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Nov; 15(11):649-51. PubMed ID: 8732147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.